Drug Profile
Research programme: broad spectrum chemokine inhibitors - Funxional Therapeutics
Alternative Names: FX141L; FX87LLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Funxional Therapeutics
- Class Small molecules
- Mechanism of Action Chemokine inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in United Kingdom (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in United Kingdom (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in United Kingdom (Topical)